Loading insider details...
Beta
Latest Form 4 (May 5, 2026): Disposition to Issuer of 45,000 TERN shares.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| May 5, 2026 | Terns Pharmaceuticals, Inc. (TERN) | Disposition to Issuer | 45,000 | n/a |
| May 1, 2026 | Avalyn Pharma Inc. (AVLN) | Grant/Award | 26,978 | n/a |
| Feb 2, 2026 | Terns Pharmaceuticals, Inc. (TERN) | Grant/Award | 1,697 | n/a |
| Sep 12, 2025 | LB PHARMACEUTICALS INC (LBRX) | Disposition to Issuer | 175,706 | n/a |
| Jun 12, 2025 | Terns Pharmaceuticals, Inc. (TERN) | Grant/Award | 45,000 | n/a |
| Nov 19, 2024 | Terns Pharmaceuticals, Inc. (TERN) | Grant/Award | 64,000 | n/a |
| Mar 18, 2022 | Lyell Immunopharma, Inc. (LYEL) | Grant/Award | 300,000 | n/a |